Leslie Fecher

  • 2383 Citations
  • 13 Scopus h-Index
20072024

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Melanoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Skin Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases Medicine & Life Sciences
Merkel Cell Carcinoma Medicine & Life Sciences
Hydroxychloroquine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2017

Merkel Cell Carcinoma
Clinical Trials
Neoplasms
nivolumab
Publications
3 Citations

Acute visual loss after ipilimumab treatment for metastatic melanoma

Wilson, M. A., Guld, K., Galetta, S., Walsh, R. D., Kharlip, J., Tamhankar, M., McGettigan, S., Schuchter, L. M. & Fecher, L. A. Oct 18 2016 In : Journal for ImmunoTherapy of Cancer. 4, 1, 66

Research output: Research - peer-reviewArticle

Melanoma
Therapeutics
ipilimumab
Optic Neuritis
Steroids
6 Citations

Metastatic Merkel cell carcinoma response to nivolumab

Walocko, F. M., Scheier, B. Y., Harms, P. W., Fecher, L. A. & Lao, C. D. Nov 15 2016 In : Journal for ImmunoTherapy of Cancer. 4, 1, 79

Research output: Research - peer-reviewArticle

Merkel Cell Carcinoma
nivolumab
Therapeutics
Immune Evasion
Immunotherapy
47 Citations

Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

Weber, J. S., Gibney, G., Sullivan, R. J., Sosman, J. A., Slingluff, C. L., Lawrence, D. P., Logan, T. F., Schuchter, L. M., Nair, S., Fecher, L., Buchbinder, E. I., Berghorn, E., Ruisi, M., Kong, G., Jiang, J., Horak, C. & Hodi, F. S. Jul 1 2016 In : The Lancet Oncology. 17, 7, p. 943-955 13 p.

Research output: Research - peer-reviewArticle

Melanoma
ipilimumab
nivolumab
Therapeutics
Survival
2 Citations

Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – Role of smoothened inhibitors

Fecher, L. A. & Sharfman, W. H. Nov 6 2015 In : Biologics: Targets and Therapy. 9, p. 129-140 12 p.

Research output: Research - peer-reviewReview article

Basal Cell Carcinoma
Therapeutics
HhAntag691
Patient Care Management
Tanning